Recombinant FVIII (Kogenate) treatment of previously untreated patients (PUPs) with hemophilia A: Update of safety, efficacy and inhibitor development after seven study years. - Lusher, J; Arkin, S; Abildgaard, CF; Hurst, D (1998)
(Abstract).